Trials / Completed
CompletedNCT02829177
Microalbuminuria and Allopurinol in Type 1 Diabetes
A Double-blind, Randomized, Placebo Controlled Trial of Allopurinol in Patients With Type 1 Diabetes and Microalbuminuria
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Peter Rossing · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to determine if lowering serum uric acid by means of allopurinol in the course of kidney disease may be effective in preventing or improving albuminuria and renal function in Type 1 Diabetic patients. The study is a double blinded, randomised, placebo-controlled cross-over clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Allopurinol | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2016-08-10
- Completion
- 2017-09-20
- First posted
- 2016-07-12
- Last updated
- 2018-09-10
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02829177. Inclusion in this directory is not an endorsement.